Follow
Ann M. Bailey
Ann M. Bailey
University of Texas MD Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development
RRM Maran, A Thomas, M Roth, Z Sheng, N Esterly, D Pinson, X Gao, ...
Journal of Pharmacology and Experimental Therapeutics 328 (2), 469-477, 2009
2432009
Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development
RRM Maran, A Thomas, M Roth, Z Sheng, N Esterly, D Pinson, X Gao, ...
Journal of Pharmacology and Experimental Therapeutics 328 (2), 469-477, 2009
2432009
Genome‐wide tissue‐specific farnesoid X receptor binding in mouse liver and intestine
AM Thomas, SN Hart, B Kong, J Fang, X Zhong, GL Guo
Hepatology 51 (4), 1410-1419, 2010
2092010
A decision support framework for genomically informed investigational cancer therapy
F Meric-Bernstam, A Johnson, V Holla, AM Bailey, L Brusco, K Chen, ...
Journal of the National Cancer Institute 107 (7), djv098, 2015
2002015
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol
F Meric-Bernstam, L Brusco, M Daniels, C Wathoo, AM Bailey, L Strong, ...
Annals of Oncology 27 (5), 795-800, 2016
1782016
ALK: a tyrosine kinase target for cancer therapy
VR Holla, YY Elamin, AM Bailey, AM Johnson, BC Litzenburger, ...
Molecular Case Studies 3 (1), a001115, 2017
1722017
The Chelsea critical care physical assessment tool (CPAx): validation of an innovative new tool to measure physical morbidity in the general adult critical care population; an …
EJ Corner, H Wood, C Englebretsen, A Thomas, RL Grant, D Nikoletou, ...
Physiotherapy 99 (1), 33-41, 2013
1612013
Nontuberculous mycobacterial disease following hot tub exposure.
EJ Mangione, G Huitt, D Lenaway, J Beebe, A Bailey, M Figoski, MP Rau, ...
Emerging infectious diseases 7 (6), 1039, 2001
1562001
Increased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice
A Wolfe, A Thomas, G Edwards, R Jaseja, GL Guo, U Apte
Journal of Pharmacology and Experimental Therapeutics 338 (1), 12-21, 2011
1292011
1-Deoxy-d-Xylulose 5-Phosphate Reductoisomerase (IspC) from Mycobacterium tuberculosis: towards Understanding Mycobacterial Resistance to Fosmidomycin
RK Dhiman, ML Schaeffer, AM Bailey, CA Testa, H Scherman, DC Crick
Journal of bacteriology 187 (24), 8395-8402, 2005
1192005
Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis
RA Larsen, M Bauer, AM Thomas, JR Graybill
Antimicrobial agents and chemotherapy 48 (3), 985-991, 2004
1112004
FXR silencing in human colon cancer by DNA methylation and KRAS signaling
AM Bailey, L Zhan, D Maru, I Shureiqi, CR Pickering, G Kiriakova, J Izzo, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 306 (1 …, 2014
812014
Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps
AM Bailey, Y Mao, J Zeng, V Holla, A Johnson, L Brusco, K Chen, ...
Discovery medicine 17 (92), 101, 2014
782014
Dose‐response impact of various tocotrienols on serum lipid parameters in 5‐week‐old female chickens
SG Yu, AM Thomas, A Gapor, B Tan, N Qureshi, AA Qureshi
Lipids 41 (5), 453, 2006
752006
Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis
DAM Diamond, M Bauer, BE Daniel, MAE Leal, D Johnson, BK Williams, ...
Antimicrobial agents and chemotherapy 42 (3), 528-533, 1998
721998
Precision oncology decision support: current approaches and strategies for the future
KC Kurnit, EEI Dumbrava, B Litzenburger, YB Khotskaya, AM Johnson, ...
Clinical Cancer Research 24 (12), 2719-2731, 2018
662018
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies
MJ Reilley, A Bailey, V Subbiah, F Janku, A Naing, G Falchook, D Karp, ...
Journal for immunotherapy of cancer 5, 1-10, 2017
652017
Identification, cloning, purification, and enzymatic characterization of Mycobacterium tuberculosis 1-deoxy-d-xylulose 5-phosphate synthase
AM Bailey, S Mahapatra, PJ Brennan, DC Crick
Glycobiology 12 (12), 813-820, 2002
652002
The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform
A Johnson, J Zeng, AM Bailey, V Holla, B Litzenburger, H Lara-Guerra, ...
Drug discovery today 20 (12), 1433-1438, 2015
622015
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer
JM Loree, AM Bailey, AM Johnson, Y Yu, W Wu, CA Bristow, JS Davis, ...
JNCI: Journal of the National Cancer Institute 110 (12), 1409-1417, 2018
602018
The system can't perform the operation now. Try again later.
Articles 1–20